The effects of weight loss and other nonpharmacologic interventions on blood pressure Dalila B. CorryMichael L. Tuck Clinical Trials Review Pages: 118 - 118
Obesity, hypertension, and sympathetic nervous system activity Dalila B. CorryMichael L. Tuck OriginalPaper Pages: 119 - 126
Obesity and cardiovascular hemodynamic function Rainer KochArya M. Sharma OriginalPaper Pages: 127 - 130
Obesity, hypertension, and vascular disease Kurt M. R. SowersJames R. Sowers OriginalPaper Pages: 140 - 144
Obesity, blood pressure, and renal sodium handling Myron H. Weinberger OriginalPaper Pages: 145 - 148
The salt-blood pressure controversy: What are the issues? Myron H. Weinberger Clinical Trials Review Pages: 149 - 150
Novel actions of angiotensin II via its renal type-2 (AT2) receptor Robert M. CareyZhi-Qin WangHelmy M. Siragy OriginalPaper Pages: 151 - 157
Antihypertensive drugs and diabetic nephropathy Philip S. MehlerRobert W. Schrier OriginalPaper Pages: 170 - 177
Role of nitric oxide in the control of renal function and salt sensitivity Ai-Ping ZouAllen W. Cowley Jr OriginalPaper Pages: 178 - 186
New insights into the renin-angiotensin system and hypertensive renal disease Agnes B. Fogo OriginalPaper Pages: 187 - 194
